<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04869319</url>
  </required_header>
  <id_info>
    <org_study_id>QI-A1C</org_study_id>
    <nct_id>NCT04869319</nct_id>
  </id_info>
  <brief_title>Electronic Triggers: Messaging After A1C EHR Alert</brief_title>
  <official_title>Electronic Triggers: Messaging After A1C EHR Alert</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studying subjects with HbA1C tests &gt;10 and no follow-up test within 6 months and appointments&#xD;
      scheduled in the next 60 days from data run date. Subjects who receive intervention message&#xD;
      may be more likely to follow up with their provider to schedule a follow up HbA1C test.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 13, 2020</start_date>
  <completion_date type="Anticipated">July 13, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 13, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Follow up A1C within 9 months after original A1C (allowing 3 months after email is sent)</measure>
    <time_frame>1 year</time_frame>
    <description>This outcome measures the rate at which participants complete an A1C test within 3 months of the message intervention being sent and 9 months of their original test.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">712</enrollment>
  <condition>Hemoglobins</condition>
  <condition>Diagnostic Tests</condition>
  <arm_group>
    <arm_group_label>MyChart message</arm_group_label>
    <description>MyChart message subjects with high A1C blood tests to help manage their diabetes and prevent some of the complications caused by high sugars. The message recommends that they schedule a visit with their doctor who can recheck the blood test and help get their diabetes under control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No MyChart message</arm_group_label>
    <description>No message</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MyChart message</intervention_name>
    <description>Message subjects through MyChart to follow-up with their provider to schedule a follow up HbA1C test.</description>
    <arm_group_label>MyChart message</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        MyChart active patients with HbA1C tests &gt;10 and no follow-up test within 6 months and&#xD;
        appointments scheduled in the next 60 days from data run date&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  MyChart active patients with HbA1C tests &gt;10 and no follow-up test within 6 months and&#xD;
             appointments scheduled in the next 60 days from data run date&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a scheduled appointment within 60 days from time algorithim is run;&#xD;
             hospital encounters; non English or Spanish patients as indicated by primary language&#xD;
             in Epic&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>April 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2021</study_first_posted>
  <last_update_submitted>July 6, 2021</last_update_submitted>
  <last_update_submitted_qc>July 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

